October 18, 2011
Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements Dr. J. Kellogg Parsons Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer…
September 25, 2013
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.
April 25, 2023
New UC San Diego Health transperineal prostate biopsy procedure now offered in clinic setting.
July 9, 2018
Physicians at UC San Diego Health are now offering prostate artery embolization as a new treatment option for men with benign prostatic hyperplasia, or an enlarged prostate. The minimally invasive procedure is an alternative to surgery, with no hospital stay, little operative pain and lower cost.
October 11, 2011
…international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results of this update will appear October 12, 2011, in the Journal of the…
April 29, 2015
…and the immune cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.
October 5, 2022
UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics.
October 31, 2022
Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.
May 6, 2019
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.
February 7, 2013
…its first-ever fundraiser for prostate cancer research, “Breakfast with Champions,” on Friday, Feb. 22 at the La Jolla Country Club. The event will feature Pro Football Hall of Famers and prostate cancer survivors Mike Haynes and Deacon Jones who will discuss their experiences as champions, both on and off the…
